Search Results - "Food and Drug Administration"

Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma by Jain MD, Bachmeier CA, Phuoc VH, Chavez JC

Connect to this object online.

Pharmacogenetic information for patients on drug labels by Haga SB, Mills R, Moaddeb J

Connect to this object online.

Opana ER (Oxymorphone)-Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C by Hassan Mehmood MD, Muzammil Khan MD, Asghar Marwat MD, Medha Joshi MD, Varun Malhotra MD

Connect to this object online.

Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network by Ryogo Umetsu, Mizuki Tanaka, Yoko Nakayama, Yamato Kato, Natsumi Ueda, Yuri Nishibata, Shiori Hasegawa, Kiyoka Matsumoto, Noriaki Takeyama, Kazuhiro Iguchi, Hiroyuki Tanaka, Eiichi Hinoi, Eiichi Hinoi, Naoki Inagaki, Masatoshi Inden, Yoshinori Muto, Mitsuhiro Nakamura

Connect to this object online.

A Regulatory Perspective on Biosimilar Medicines by Marta Agostinho Cordeiro, Carla Vitorino, Carlos Sinogas, João J. Sousa

Connect to this object online.

A critical appraisal of atomoxetine in the management of ADHD by Childress AC

Connect to this object online.

Antibodies to watch in 2022 by Hélène Kaplon, Alicia Chenoweth, Silvia Crescioli, Janice M. Reichert

Connect to this object online.

Topical Insights Into the Post-Approval Controversies of Aducanumab by Dhiraj Kumar, Dharmendra Kumar Yadav, Md Imtaiyaz Hassan

Connect to this object online.

FDA's Strategies to Close the Health Equity Gap among Diverse Populations by Jovonni Spinner, RADM Richardae Araojo

Connect to this object online.

Spinal Muscular Atrophy - The disease and its treatments by Kyra Y. Chen

Connect to this object online.

Optimizing polymerase chain reaction testing for the diagnosis of pertussis: current perspectives by Arbefeville S, Ferrieri P

Connect to this object online.

Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database by Nayara Aparecida de Oliveira Silva, Ana Laura de Sene Amâncio Zara, Albert Figueras, Daniela Oliveira de Melo

Connect to this object online.

Modern pharmacological treatments of sexual dysfunction in women: a narrative review by Marzieh Saei Ghare Naz, Marzieh Rostami Dovom, Fahimeh Ramezani Tehrani

Connect to this object online.

Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment by Giovanna Menduti, Daniela Maria Rasà, Serena Stanga, Marina Boido

Connect to this object online.

Comparative analysis of the heavy metals content in selected colored cosmetic products at Saudi market by Rasha Saad Suliman, Sahar Saleh Alghamdi, Dilshad Ahmad, Rahaf Ibrahim Alghamdi, Raghad Alotaibi, Munirah Alghwainm, Norah A Aljammaz

Connect to this object online.

Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters by Hyosun Kim

Connect to this object online.

Antibodies to watch in 2021 by Hélène Kaplon, Janice M. Reichert

Connect to this object online.

Demonstration of Equivalence of Generic Glatiramer Acetate and Copaxone® by Peter Lipsky, Patrick T. Vallano, Jeffrey Smith, Walter Owens, Daniel Snider, Viswanath Bandaru, Yunfu Sun, Ross Wallingford, Joseph Duncan, Joshua Lewis, Jason Southall, Azeem Ansari, Hong Li

Connect to this object online.

Representation of sex, race, and ethnicity in pivotal clinical trials for dermatological drugs by Jeffrey Ding, Youwen Zhou, MD, PhD, FRCPC, Muhammad Shahzeb Khan, MD, MSc, Rebecca N. Sy, Faisal Khosa, MD, MBA, FFRRCSI, FRCPC

Connect to this object online.

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib by Xusheng Zhang, Xiuli Ren, Tianyu Zhu, Wanjin Zheng, Wanjin Zheng, Chengwu Shen, Cuicui Lu

Connect to this object online.